Thrive Capital

Venture Capital

Portfolio

companies

Portfolio companies

Isomorphic Labs

Isomorphic Labs develops artificial intelligence systems to design new therapeutics and accelerate drug discovery.

Team

Joshua Kushner

Founder and CEO of Thrive Capital

Recent investments

Other31 March 2025

£459M

Isomorphic Labs secures £458.6m in a funding round led by Thrive Capital to advance its artificial intelligence drug design engine.

AI/ML BioTech

The financing round was led by Thrive Capital with backing from GV and Alphabet.

"We’re excited to bring together a top-tier investor group with deep AI and life sciences expertise as we aim to transform this industry through an interdisciplinary approach."

— Sir Demis Hassabis, Founder and CEO

Isomorphic Labs—London, UK

Thrive Capital + 2 others